APVO - CIK 0001671584
Aptevo Therapeutics Inc. has filed 690 documents with the SEC between 2016 and 2026. The most frequent type is insider trade (221 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2022-08-10 | 2022-08-09 |
| Insider trade | 4 | 2022-08-10 | 2022-08-09 |
| Insider trade | 4 | 2022-08-10 | 2022-08-09 |
| Major company event | 8-K | 2022-06-09 | 2022-06-09 |
| Major company event | 8-K | 2022-06-08 | 2022-06-07 |
| Employee stock plan | S-8 | 2022-06-07 | - |
| Major company event | 8-K | 2022-06-07 | 2022-06-07 |
| Insider trade | 4 | 2022-06-07 | 2022-06-07 |
| Insider trade | 4 | 2022-06-07 | 2022-06-07 |
| Insider trade | 4 | 2022-06-07 | 2022-06-07 |
| Insider trade | 4 | 2022-06-03 | 2022-06-01 |
| Insider trade | 4 | 2022-06-03 | 2022-06-01 |
| Insider trade | 4 | 2022-06-03 | 2022-06-01 |
| Insider trade | 4 | 2022-06-03 | 2016-08-03 |
| Insider trade | 4 | 2022-06-03 | 2022-06-01 |
| Insider trade | 4 | 2022-06-03 | 2022-06-01 |
| Major company event | 8-K | 2022-05-31 | 2022-05-26 |
| Quarterly report | 10-Q | 2022-05-12 | 2022-03-31 |
| Major company event | 8-K | 2022-05-12 | 2022-05-12 |
| Proxy statement | DEF 14A | 2022-04-27 | 2022-06-07 |
| Major company event | 8-K | 2022-04-07 | 2022-04-01 |
| Major company event (amended) | 8-K/A | 2022-03-30 | 2022-03-29 |
| Major company event | 8-K | 2022-03-29 | 2022-03-29 |
| Prospectus supplement | 424B5 | 2022-03-29 | - |
| Prospectus supplement | 424B5 | 2022-03-24 | - |
| Annual report | 10-K | 2022-03-24 | 2021-12-31 |
| Major company event | 8-K | 2022-03-24 | 2022-03-24 |
| Insider trade | 4 | 2022-03-04 | 2022-03-04 |
| Insider trade | 4 | 2022-03-04 | 2022-03-04 |
| Insider trade | 4 | 2022-03-04 | 2022-03-04 |
| Major company event | 8-K | 2022-02-18 | 2022-02-18 |
| Prospectus supplement | 424B5 | 2022-02-18 | - |
| Major company event | 8-K | 2022-02-17 | 2022-02-16 |
| Passive ownership stake (update) | SC 13G/A | 2022-02-10 | - |
| Major company event | 8-K | 2022-02-09 | 2022-02-09 |
| Insider trade | 4 | 2022-02-01 | 2022-01-29 |
| Insider trade | 4 | 2022-02-01 | 2022-01-29 |
| Major company event | 8-K | 2022-01-21 | 2022-01-21 |
| Insider trade | 4 | 2021-12-07 | 2021-12-03 |
| Activist ownership stake (update) | SC 13D/A | 2021-11-26 | - |
| Insider trade | 4 | 2021-11-26 | 2021-11-23 |
| Major company event | 8-K | 2021-11-23 | 2021-11-23 |
| Activist ownership stake (update) | SC 13D/A | 2021-11-22 | - |
| Insider trade | 4 | 2021-11-22 | 2021-11-18 |
| Major company event | 8-K | 2021-11-12 | 2021-11-12 |
| Quarterly report | 10-Q | 2021-11-12 | 2021-09-30 |
| Major company event | 8-K | 2021-11-05 | 2021-11-05 |
| Major company event | 8-K | 2021-08-27 | 2021-08-25 |
| EFFECT | - | 2021-08-19 | - |
| Company correspondence | CORRESP | 2021-08-17 | - |